33 days until earnings call
Interact to see
Advertisement
Advertisement
GINX vs GSK
GINX vs GSK Comparison
Open Charts GINX vs GSK
SGI Enhanced Global Income ETF
Price$29.35
Change+$0.20 (+0.69%)
Volume$115
Net Assets83.95M
GINX vs GSK Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
GINX vs. GSK commentary
Sep 27, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GINX is a Hold and GSK is a StrongBuy.
SUMMARIES
FUNDAMENTALS RATINGS
GSK: Fundamental Ratings
GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 76 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 6 Undervalued | |
PROFIT vs RISK RATING 1..100 | 65 | |
SMR RATING 1..100 | 40 | |
PRICE GROWTH RATING 1..100 | 54 | |
P/E GROWTH RATING 1..100 | 21 | |
SEASONALITY SCORE 1..100 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TECHNICAL ANALYSIS
Technical Analysis
| GINX | GSK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 40% | 2 days ago 51% |
| Stochastic ODDS (%) | 2 days ago 90% | 2 days ago 47% |
| Momentum ODDS (%) | 2 days ago 56% | 2 days ago 50% |
| MACD ODDS (%) | 2 days ago 63% | 2 days ago 48% |
| TrendWeek ODDS (%) | 2 days ago 66% | 2 days ago 51% |
| TrendMonth ODDS (%) | 2 days ago 54% | 2 days ago 46% |
| Advances ODDS (%) | 10 days ago 88% | 5 days ago 59% |
| Declines ODDS (%) | 2 days ago 59% | 2 days ago 52% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 60% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 45% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
GINX and
Correlation & Price change
A.I.dvisor tells us that GINX and GSK have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GINX and GSK's prices will move in lockstep.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To GINX | 1D Price Change % | ||
|---|---|---|---|---|
| GINX | 100% | -0.86% | ||
| GSK - GINX | 23% Poorly correlated | -1.64% | ||
| KMB - GINX | 22% Poorly correlated | -1.78% | ||
| FMS - GINX | 22% Poorly correlated | -2.44% | ||
| RELX - GINX | 21% Poorly correlated | -0.19% | ||
| SONY - GINX | 20% Poorly correlated | +1.67% | ||
More | ||||
GSK and
Correlation & Price change
A.I.dvisor indicates that over the last year, GSK has been closely correlated with NVS. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if GSK jumps, then NVS could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y